| Net income attributable to AAR and noncontrolling interest | |
| Depreciation and amortization | 12.4M |
| Amortization of stock-based compensation | 2.5M |
| Amortization of debt discount | |
| Deferred tax provision | -900K |
| Tax benefits from exercise of stock options | |
| Impairment charges | |
| Gain on extinguishment of debt | |
| Loss on sale of investment | |
| Gain on sale of product line | |
| Earnings from joint ventures | |
| Accounts and notes receivable | |
| Inventories | 3M |
| Rotable spares and equipment on or available for short-term lease | -700K |
| Equipment on long-term lease | -17.3M |
| Accounts and trade notes payable | -8.4M |
| Accrued and other liabilities | -5.8M |
| Other, primarily deposits and program costs | |
| Net cash provided from operating activities | -1.1M |
| Property, plant and equipment expenditures | -9.4M |
| Proceeds from disposal of assets | 3M |
| Proceeds from sale of product line | |
| Proceeds from disposal of business | |
| Proceeds from sale of available for sale securities | |
| Company acquired, net of cash | |
| Proceeds from aircraft joint ventures | -200K |
| Investment in aircraft joint ventures | |
| Proceeds from leveraged leases | |
| Other | |
| Net cash used in investing activities | -6.6M |
| Change in short-term borrowings, net | |
| Reduction in borrowings, net | |
| Reduction in capital lease obligations | |
| Reduction in equity due to convertible bond repurchase | |
| Cash dividends | -2.6M |
| Purchase of treasury stock | -14.8M |
| Stock option exercises | |
| Tax benefits from exercise of stock options | |
| Contributions from noncontrolling interest | |
| Net cash provided from (used in) financing activities | |
| Effect of exchange rate changes on cash | -400K |
| Increase (decrease) in cash and cash equivalents | -23.3M |
| Cash and cash equivalents, beginning of year | 31.2M |
| Cash and cash equivalents, end of year | 7.9M |